Blockchain in Healthcare Market

Blockchain in Healthcare Market: Distribution by Application, Type of Blockchain, Type of End User, and Key Geographical Regions (North America, Europe, Asia-Pacific, and Rest of the World): Industry Trends and Global Forecasts, 2023-2035

  • Lowest Price Guaranteed From USD 4,799

  • Published
    January 2023

  • Pages
    165

  • View Count
    3345

Example Insights

The image provides context of blockchain in drug discovery and clinical trials. Given the potential of blockchain to optimize process timelines, while ensuring data privacy and integrity, this technology has garnered significant attention within the pharmaceutical industry This image provides list of blockchain technology providers. Presently, more than 50 players claim to provide blockchain platform solutions across a wide range of drug development applications The image provides details on the current blockchain technology providers landscape. The current market landscape features stakeholders offering blockchain technology to industries for various drug development applications; majority of these technology platforms are being used for clinical trial management
The image looks at the competitive landscape across blockchain technology providers. In pursuit of building a competitive edge, stakeholders are striving to enhance their existing capabilities and upgrade their proprietary blockchain platforms with advanced features This infographic provides details on publications related to blockchain. Around 37% of the articles focused on the use of blockchain technology in the pharmaceutical industry have been published in the year 2022, highlighting the substantial efforts undertaken by researchers The image provides details on the partnerships and collaborations deals inked by players involved in blockchain. The growing interest is also prevalent from the recent rise in partnership activity; ~60% of the deals, so far, have been focused on utilization and integration of proprietary blockchain platforms
This infographic provides details on strengths, weaknesses, opportunies and threats related to blockchain technology. The increasing demand for blockchain in clinical research, especially for drug discovery and clinical trials, is anticipated to create lucrative business opportunities within this field This image provides details on blockchain market size. We expect the market to witness an annualized growth of 22% in the coming decade; the opportunity is likely to be well distributed across various types of blockchain, types of end-users and key geographical regions  

Report Description

Blockchain in Healthcare Market Overview

The global blockchain in healthcare market size is estimated to be worth USD 58 million in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 22%, during the forecast period. The conventional healthcare industry was plagued with various challenges, including fragmented medical records, lack of data integrity, interoperability issues, supply chain management inefficiencies and security breach of patient’s sensitive medical information. Further, approximately 80% of the medical studies fail to produce the desired results due to errors such as fraud, data falsification and trial misconduct. It is important to mention that more than 690 healthcare data breaches were reported between July 2021 and June 2022. As a result, the adoption of blockchain technology (also referred to as distributed ledger technology (DLT)), has emerged to be a promising approach. This innovative technology appropriately identifies dangerous mistakes in the medical industry; it also facilitates safe storage and management of healthcare data and transactions. In addition, the blockchain applications include clinical trials (to prevent data manipulation and enhance transparency of clinical trial data), supply chain management (to reduce the prevalence of counterfeit medications / drugs), telemedicine (to protect medical records from unauthorized access or tampering) and electronic medical records (to facilitate patients’ data security between different healthcare providers).  

Key Market Insights

The Blockchain in Healthcare Market: Distribution by Application (Drug Discovery, Clinical Trials) Type of Blockchain (Public Blockchain, Private Blockchain, Hybrid Blockchain, and Other Blockchains), Type of End User (Hospitals, Pharmaceutical Industry, Research Institutes and Academic Institutes), and Key Geographical Regions (North America, Europe, Asia-Pacific, and Rest of the World): Industry Trends and Global Forecasts, 2023-2035 market report features an extensive study of the current market landscape, market size and future opportunity for the companies offering blockchain technology in healthcare market for application in drug discovery and clinical trials, during the given forecast period. Key takeaways from the market report are briefly discussed below. 

What is Blockchain and How Does it Work?

Blockchain is a decentralized, distributed, digital ledger that is used to record transactions on a common digital platform. It is worth noting, that the record cannot be altered retroactively without the alteration of all subsequent blocks and the consensus of the network. Further, the technology was developed to facilitate secure transactions between different stakeholders, without involving third parties. There are few simple steps on which blockchain works:

  • Each transaction being performed is recorded along with relevant details
  • The different nodes of the network verify if the transaction is valid
  • Each transaction being verified is added to the block
  • Once the block is complete, it is added to the chain

Market Landscape: Blockchain in Healthcare Market

The current market landscape features more than 50 companies that are engaged in offering blockchain technology for healthcare industry. Overall, the market seems to be well-fragmented, featuring the presence of very small, small, mid-sized, large, and very large companies. More than 50% of the companies engaged in this industry are headquartered in North America, followed by companies based in Europe (32%). Some examples of blockchain platform providers, include ConsenSys, Embleema, Equideum Health, IBM lifescience, MELLODDY  and Pistoia Alliance.

Majority (56%) of the blockchain technology platform providers offer public blockchain; these are also referred to as permissionless blockchain that allow anyone to participate in the network. Further, the blockchain technology platforms are primarily used in clinical trial management for patient data management, operational excellence, and patient recruitment and retention.

Market Trend Analysis: Partnership and Collaboration on the Rise for Blockchain Technology

Several stakeholders have been forging alliances related to blockchain in healthcare, specifically for application in drug discovery and clinical trials with pharmaceutical companies for platform utilization, platform integration and platform development purposes. It is interesting to note that in September 2022, Mayo Clinic entered into a partnership with Triall to use the latter company’s blockchain platform, to optimize the integrity of the former company’s clinical trial design and manage healthcare data.  Further, in March 2022, Triall entered into an agreement with Crucial Data Solutions to integrate its blockchain platform with the latter company’s eClinical solutions; both the companies aim to strengthen data security and integrity.  The collaboration of blockchain companies with other technology providers will help in increasing the applicability of the platform specifically for conducting / supporting decentralized clinical trials. Such trends will drive the blockchain in healthcare market growth during the forecast period. 

Market Trend Analysis: Increase in Publications Reflect the Rising Interest in Blockchain in Healthcare Market

More than 510 scientific articles related to this industry have been published (in journals having different impact factors), over a period of six years, highlighting the substantial efforts made by researchers. Around 60% of these publications were research articles. In addition, the maximum number of articles focused on blockchain technology in the pharma sector were published by Multidisciplinary Digital Publishing Institute (MDPI), followed by Journal of Medical Internet Research and Frontiers Media. 

Blockchain in Healthcare Market Size: Asia Pacific to Hold the Largest Market Share

The blockchain in healthcare market, for application in drug discovery and clinical trials, in Asia-Pacific is likely to capture the largest market share (46%). Additionally, in terms of type of blockchain, public blockchain is anticipated to capture maximum share in the market, in the foreseen future. In terms of end user, presently, around 40% of the revenue generation potential is associated with hospitals using proprietary blockchain platforms for drug discovery and clinical trials. The blockchain in healthcare market is valued at USD 58 million in 2023 and is anticipated to grow at a CAGR of 22% during the forecast period.

Key Drivers for the use of Blockchain Technology in Healthcare Market

In recent years, the use of blockchain has been on the rise, driven by the growing demand for methods that safeguard sensitive healthcare data, shift towards digital health records and ongoing technological advancements. Blockchain provides a strong platform for enhanced clinical practice in terms of maintaining patient records and enrolling patients for trials. It also enhances the storage and transparency of medical data. In addition, the ledger can be used to contain all the updated information along with an encrypted patient identity to secure patient data. Owing to the benefits offered by blockchain technology in healthcare, we expect the pharmaceutical companies to start adopting the platform for clinical trials, supporting the market growth over the forecast period. In July 2022, Japan based Aculys Pharma announced its plans to use a blockchain platform from SUSMED to conduct a clinical trial. 

Leading Blockchain Healthcare Companies 

Examples of key companies offering blockchain technology in healthcare market (which have also been captured in this market report) include (in alphabetic order) Alten Calsoft Labs, ConsenSys, Humanscape, Hyperledger Foundation, IBM, Infosys, Innoplexus, Medsphere, Solulab Stratumn and Tech Mahindra. This market report includes an easily searchable, excel database of all the companies offering blockchain for healthcare applications.

Recent Developments in Blockchain in Healthcare Market

Several recent developments have taken place in the field of blockchain in healthcare market, some of which have been outlined below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that we have outlined in our analysis.

  • In August 2023, Solve.Care announced the launch of a blockchain based Care.Trials network, a patient matching service for clinical trials. 
  • In April 2023, PharmaLedger introduced electronic product information (ePI) on blockchain product. This product will allow the patient to scan a barcode on the medicine box to access the product information, replacing the leaflets currently seen in the package. 

Scope of the Report

The blockchain in healthcare market report features an in-depth analysis of various firms / organizations that are engaged in this industry, across different segments as defined in the below table: 

Key Report Attributes Details

Base Year

2023

Forecast Period

2023 – 2035

Market Size 2023

$58 million

CAGR

22%

Type of Blockchain
  • Public Blockchain
  • Private Blockchain
  • Hybrid Blockchain 
  • Others
Type of End User
  • Healthcare Industry
  • Pharmaceutical Industry
  • Government Organizations, and Universities
Key Geographical Regions
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
Key Companies Profiled
  • Alten Calsoft Labs
  • ConsenSys
  • Humanscape
  • Hyperledger Foundation
  • IBM
  • Infosys
  • Innoplexus
  • Medsphere
  • Solulab
  • Stratumn
  • Tech Mahindra
PowerPoint Presentation (Complimentary)
  • Available

Customization Scope

  • 15% Free Customization

Excel Data Packs (Complimentary)

  • Market Landscape Analysis
  • Company Competitiveness Analysis
  • Partnerships and Collaborations
  • Publication Analysis
  • Market Forecast and Opportunity Analysis

The market report presents an in-depth analysis, highlighting the capabilities of various companies engaged in this industry, across different geographies. Amongst other elements, the research report features:

  • A preface providing an introduction to the full report, Blockchain in Healthcare Market (Drug Discovery and Clinical Trials), 2023-2035.
  • An executive summary of the insights captured during our research. It offers a high-level view on the current state of blockchain in healthcare market with application in drug discovery and clinical trials and its likely evolution in the short to mid and long term.
  • A general overview of blockchain technology, along with information on its types and applications across various industries. It also highlights the applications of blockchain, specifically in drug discovery and clinical trials. Further, the chapter features a discussion on the challenges, key growth drivers, and future perspectives associated with the use of blockchain in drug discovery and clinical trials.
  • A detailed assessment of the overall market landscape of healthcare companies using blockchain technology for  drug discovery and clinical trials, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of blockchains (public blockchain, private blockchain, and consortium blockchain), type of drug development applications (drug discovery, intellectual property management, electronic health record management, vaccine distribution, drug authenticity, drug supply chain, drug data management, clinical trial management, and electronic signatures), applications within clinical trial management (operational excellence, predictive analysis, site investigation, patient recruitment retention, vendor management, patient data management, risk based monitoring, and data visualization), and type of end users (healthcare industry, pharmaceutical industry, and government organizations).
  • A detailed competitiveness analysis of blockchain technology providers based on supplier strength (in terms of the years of experience), portfolio diversity (in terms of type of drug development applications, applications within clinical trial management and type of end users), and portfolio strength (in terms of type of blockchains).
  • Elaborate profiles of key companies providing blockchain platforms for drug discovery applications. Each profile includes a brief overview of the company, financial information (if available), details on application areas of proprietary platform, recent developments and an informed future outlook.
  • A detailed analysis of the partnerships established between stakeholders in this industry, since 2017, covering platform utilization agreements, platform integration agreements, strategic alliances, platform development agreements, service agreements, service alliances, acquisitions, research agreements and other relevant agreements.
  • A detailed review of more than 500 peer-reviewed, scientific articles focused on blockchain in the pharmaceutical industry, based on several relevant parameters, such as year of publication, type of publication, popular publishers, popular copyright holders and keywords. The chapter also highlights the top journals, in terms of number of articles published and impact factor.
  • A discussion on affiliated trends, key drivers, and challenges under a SWOT framework, which are likely to impact the industry’s evolution highlighting the relative effect of each SWOT parameter on the overall blockchain in healthcare market (drug discovery and clinical trials).
  • A case study highlighting the applications of blockchain across various industries, such as healthcare, banking and financial, automotive, education, telecom, transportation and travel industries, and its likely evolution in the foreseen future.

One of the key objectives of the blockchain in healthcare market report was to estimate the current opportunity and future growth potential of blockchain in drug discovery and clinical trials market over the forecast period. We have provided informed estimates on the likely evolution of the market for the forecast period, 2023-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as type of blockchain (public blockchain, private blockchain, hybrid blockchain, and other blockchains), type of end user (hospitals, pharmaceutical industry, research institutes and academic institutes) and key geographical regions (North America, Europe, Asia-Pacific, and Rest of the world). In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s evolution.

The opinions and insights presented in the market report were influenced by discussions held with stakeholders in this industry. The research report features detailed transcripts of interviews held with the industry stakeholders.

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Frequently Asked Questions

Question 1: How is blockchain useful in healthcare?

Answer: Blockchain technology is an emerging field with a potential to revolutionize the healthcare sector; the various advantages of blockchain in healthcare, include access to large datasets across different institutions, elimination of a central authority, improved transparency in transactions and reduced errors in data processing.

Question 2: What is a potential future use of blockchain technology in the healthcare industry?

Answer: The technology has emerged as a promising approach to store / exchange authentic data, reducing fraud and enhancing accountability. The technology is expected to expediate the drug development process (by enhancing transparency in clinical trials) and supporting personalized medications (by securing the sharing of genomic data).

Question 3: What are the blockchain use cases in the healthcare industry?

Answer: The blockchain use cases in healthcare include medical staff credential verification, patient data management (through EMR), smart contracts for health insurance and supply chain management.

Question 4: Which companies have recently been set up in the blockchain healthcare market?

Answer: Some examples of blockchain healthcare startups include (arranged in alphabetical order) Akiri, Blockpharma, BurstIQ, Doc.AI, Medicalchain , Mediconnect and PharmaLedger.

Question 5: What is the most common type of partnership models being adopted by stakeholders engaged in this market?

Answer: Platform utilization emerged as the most popular type of partnership model adopted by players engaged in blockchain for healthcare (drug discovery and clinical trials) industry. This is followed by platform integration agreements and strategic alliances.

Question 6: What is the market for blockchain in healthcare?

Answer: The global blockchain in healthcare market is estimated to be worth USD 58 million in 2023.

Question 7: What is the anticipated market growth (CAGR) for the blockchain market in healthcare?

Answer: The global market for blockchain in healthcare is expected to reach USD 641 million in 2035, with an annualized market growth rate (CAGR) of 22%.

Contents

Table Of Contents

1. PREFACE
1.1. Overview
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5  Key Questions Answered
1.6. Chapter Outlines

2. EXECUTIVE SUMMARY
2.1 Chapter Overview

3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Blockchain Technology
3.2.1. Ethereum vs Hyperledger Fabric

3.3. Types of Blockchain
3.3.1. Permissionless or Public Blockchain
3.3.2. Permissioned or Private Blockchain
3.3.3. Federated or Consortium Blockchain

3.4. Applications of Blockchain Across Various Industries
3.5. Applications of Blockchain in Drug Discovery and Clinical Trials
3.6. Advantages and Limitations of Blockchain
3.7. Future Perspectives

4. MARKET OVERVIEW
4.1. Chapter Overview
4.2. List of Blockchain Technology Providers
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Region of Headquarters
4.2.4. Analysis by Location of Headquarters
4.2.5. Analysis by Year of Establishment, Company Size, and Region of Headquarters
4.2.6. Analysis by Type of Blockchain(s)
4.2.7. Analysis by Type of Drug Development Application(s)
4.2.8. Analysis by Application(s) within Clinical Trial Management
4.2.9. Analysis by Type of End-User(s)
4.2.10. Analysis by Type of Blockchain and Type of End-User(s)
4.2.11. Analysis by Type of Blockchain and Type of Drug Development Application(s)

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions / Key Parameters
5.3. Methodology
5.4. Company Competitiveness Analysis: Blockchain Technology Providers based inNorth America (Peer Group I)
5.5. Company Competitiveness Analysis: Blockchain Technology Providers based inEurope (Peer Group II)
5.6. Company Competitiveness Analysis: Blockchain Technology Providers based inAsia Pacific and RoW (Peer Group III)

6. COMPANY PROFILES
6.1. Chapter Overview
6.2. Alten Calsoft Labs
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. Application Areas of Proprietary Platform
6.2.4. Recent Developments and Future Outlook

6.3. ConsenSys
6.3.1. Company Overview
6.3.2. Application Areas of Proprietary Platform
6.3.3. Recent Developments and Future Outlook

6.4. IBM
6.4.1. Company Overview
6.4.2. Financial Information
6.4.3. Application Areas of Proprietary Platform
6.4.4. Recent Development and Future Outlooks

6.5. Stratumn
6.5.1. Company Overview
6.5.2. Application Areas of Proprietary Platform
6.5.3. Recent Development and Future Outlook

6.6. Infosys
6.6.1. Company Overview
6.6.2. Financial Information
6.6.3. Application Areas of Proprietary Platform
6.6.4. Recent Developments and Future Outlook

6.7. Tech Mahindra
6.7.1. Company Overview
6.7.2. Financial Information
6.7.3. Application Areas of Proprietary Platform
6.7.4. Recent Developments and Future Outlook

6.8. Humanscape
6.8.1. Company Overview
6.8.2. Application Areas of Proprietary Platform
6.8.3. Recent Developments and Future Outlook

6.9. Hyperledger Foundation
6.9.1. Company Overview
6.9.2. Application Areas of Proprietary Platform
6.9.3. Recent Developments and Future Outlook

6.10. Innoplexus
6.10.1. Company Overview
6.10.2. Application Areas of Proprietary Platform
6.10.3. Recent Developments and Future Outlook

6.11. Medsphere
6.11.1. Company Overview
6.11.2. Application Areas of Proprietary Platform
6.11.3. Recent Developments and Future Outlook

6.12. Solulab
6.12.1. Company Overview
6.12.2. Application Areas of Proprietary Platform
6.12.3. Recent Developments and Future Outlook

7. PARTNERSHIPS AND COLLABORATIONS
7.1. Chapter Overview
7.2. Partnership Models
7.3 Blockchain in Drug Discovery and Clinical Trials: Recent Partnerships and Collaborations
7.3.1. Analysis by Year of Partnership
7.3.2. Analysis by Type of Partnership
7.3.3. Analysis by Year and Type of Partnership
7.3.4. Analysis by Company Size and Type of Partnership
7.3.5. Most Active Players: Distribution by Number of Partnerships
7.3.6. Most Active Players: Distribution by Type of Partnership
7.3.7. Analysis by Type of Pharmaceutical Applications
7.3.8. Analysis by Type of Partner
7.3.9. Analysis by Geographical Region
7.3.9.1. Local and International Agreements
7.3.9.2. Intercontinental and Intracontinental Agreements

8. PUBLICATION ANALYSIS
8.1. Chapter Overview
8.2. Scope and Methodology
8.3. Blockchain Technology in Pharmaceutical Industry: Recent Publications
8.3.1. Analysis by Year of Publication
8.3.2. Analysis by Type of Article
8.3.3. Popular Journals: Analysis by Number of Publications
8.3.4. Popular Publishers: Analysis by Number of Publications
8.3.5. Popular Copyright Holders: Analysis by Number of Publications
8.3.6. Analysis by Popular Keywords
8.3.7. Analysis by Impact Factor
8.3.8. Popular Journals: Analysis by Journal Impact Factor

9. SWOT ANALYSIS
9.1. Chapter Overview
9.2. Blockchain in Drug Discovery and Clinical Trials: SWOT Analysis
9.3. Comparison of SWOT Factors
9.3.1. Strengths
9.3.1.1. Transparency and Traceability
9.3.1.2. Cost Reduction and Data Integrity
9.3.1.3. Safe and Secure Transactions
9.3.1.4. Patient Data Management

9.3.2. Weaknesses
9.3.2.1. Implementation Expense
9.3.2.2. Storage
9.3.2.3. Immutability of Data
9.3.2.4. High Energy Consumption

9.3.3. Threats
9.3.3.1. Blockchain is Prone to Cyber Attacks
9.3.3.2. Scalability
9.3.3.3. Lack of Regulations Issued by Legal Authorities

9.3.4. Opportunities

10. CASE STUDY: APPLICATIONS OF BLOCKCHAIN IN HEALTHCARE AND OTHER INDUSTRIES
10.1. Chapter Overview
10.2. Applications of Blockchain Across Various Industries
10.2.1 Blockchain in Healthcare
10.2.2. Blockchain in Banking and Financial Industry
10.2.3. Blockchain in Automotive Industry
10.2.4. Blockchain in Education
10.2.5. Blockchain in Telecom Industry
10.2.6. Blockchain in Transportation
10.2.7. Blockchain in Travel Industry

11. MARKET FORECAST AND OPPORTUNITY ANALYSIS
11.1. Chapter Overview
11.2. Key Assumptions and Methodology
11.3. Blockchain in Drug Discovery and Clinical Trials Market, 2023-2035
11.4. Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Type of Blockchain, 2023 and 2035
11.4.1. Blockchain in Drug Discovery and Clinical Trials Market for Public Blockchain, 2023-2035
11.4.2. Blockchain in Drug Discovery and Clinical Trials Market for Private Blockchain, 2023-2035
11.4.3. Blockchain in Drug Discovery and Clinical Trials Market for Hybrid Blockchain, 2023-2035
11.4.4. Blockchain in Drug Discovery and Clinical Trials Market for Other Blockchains, 2023-2035

11.5. Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Type of End-User, 2023 and 2035
11.5.1. Blockchain in Drug Discovery and Clinical Trials Market for Hospitals, 2023-2035
11.5.2. Blockchain in Drug Discovery and Clinical Trials Market forPharmaceutical Industry, 2023-2035
11.5.3. Blockchain in Drug Discovery and Clinical Trials Market for Research Institutes, 2023-2035
11.5.4. Blockchain in Drug Discovery and Clinical Trials Market for Academic Institutes, 2023-2035

11.6. Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Key Geographical Regions, 2023 and 2035
11.6.1. Blockchain in Drug Discovery and Clinical Trials Market in NorthAmerica, 2023-2035
11.6.2. Blockchain in Drug Discovery and Clinical Trials Market in Europe, 2023-2035
11.6.3. Blockchain in Drug Discovery and Clinical Trials Market in Asia-Pacific, 2023-2035
11.6.4. Blockchain in Drug Discovery and Clinical Trials Market in Rest of theWorld, 2023-2035

12. CONCLUDING REMARKS

13. EXECUTIVE INSIGHTS

14. APPENDIX 1: TABULATED DATA

15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 2.1 Executive Summary: Overall Market Landscape
Figure 2.2 Executive Summary: Partnerships and Collaborations
Figure 2.3 Executive Summary: Publication Analysis
Figure 2.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Historical Evolution of Blockchain Technology
Figure 3.2 Types of Blockchain
Figure 3.3 Applications of Blockchain Across Various Industries
Figure 3.4 Advantages and Limitations of Blockchain
Figure 4.1 Blockchain Technology Providers: Distribution by Year of Establishment
Figure 4.2 Blockchain Technology Providers: Distribution by Company Size
Figure 4.3 Blockchain Technology Providers: Distribution by Region of Headquarters
Figure 4.4 Blockchain Technology Providers: Distribution by Location of Headquarters
Figure 4.5 Blockchain Technology Providers: Distribution Year of Establishment, Company Size, and Region of Headquarters
Figure 4.6 Blockchain Technology Providers: Distribution by Type of Blockchain(s)
Figure 4.7 Blockchain Technology Providers: Distribution by Type of Drug Development Application(s)
Figure 4.8 Blockchain Technology Providers: Distribution by Application(s) within Clinical Trial Management
Figure 4.9 Blockchain Technology Providers: Distribution by Type of End-User(s)
Figure 4.10 Blockchain Technology Providers: Distribution by Type of Blockchain and Type of End-User(s)
Figure 4.11 Blockchain Technology Providers: Distribution by Type of Blockchain and Type of Drug Development Application(s)
Figure 5.1 Company Competitiveness Analysis: Blockchain Technology Providers based in North America (Peer Group I)
Figure 5.2 Company Competitiveness Analysis: Blockchain Technology Providers based in Europe (Peer Group II)
Figure 5.3 Company Competitiveness Analysis: Blockchain Technology Providers based in Asia Pacific and RoW (Peer Group III)
Figure 6.1 Alten Calsoft Labs: Annual Revenues, 2018- H1 2022 (EUR Billion)
Figure 6.2 Alten Calsoft Labs: Application Areas of Proprietary Platform
Figure 6.3 ConsenSys: Application Areas of Proprietary Platform
Figure 6.4 IBM: Annual Revenues, 2018- H1 2022 (USD Billion)
Figure 6.5 IBM: Application Areas of Proprietary Platform
Figure 6.6 Stratumn: Application Areas of Proprietary Platform
Figure 6.7 Infosys: Annual Revenues, 2018- H1 2022 (USD Billion)
Figure 6.8 Infosys: Application Areas of Proprietary Platform
Figure 6.9 Tech Mahindra: Annual Revenues, 2018- H1 2022 (USD Billion)
Figure 6.10 Tech Mahindra: Application Areas of Proprietary Platform
Figure 7.1 Partnerships and Collaborations: Distribution by Year of Partnership, 2017-2022
Figure 7.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 7.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 7.4 Partnerships and Collaborations: Distribution by Company Size and Type of Partnership
Figure 7.5 Most Active Partners: Distribution by Number of Partnerships
Figure 7.6 Most Active Players: Distribution by Type of Partnership
Figure 7.7 Partnerships and Collaborations: Distribution by Type of Pharmaceutical Applications
Figure 7.8 Partnerships and Collaborations: Distribution by Type of Partner
Figure 7.9 Partnerships and Collaborations: Local and International Agreements
Figure 7.10 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 8.1 Publication Analysis: Cumulative Year-wise Trend, 2016-2022
Figure 8.2 Publication Analysis: Distribution by Type of Article
Figure 8.3 Popular Journals: Distribution by Number of Publications
Figure 8.4 Popular Publishers: Distribution by Number of Publications
Figure 8.5 Popular Copyright Holders: Distribution by Number of Publications
Figure 8.6 Word Cloud: Key Focus Areas
Figure 8.7 Publication Analysis: Distribution by Impact Factor
Figure 8.8 Popular Journals: Distribution by Journal Impact Factor
Figure 9.1 Blockchain Technology in Pharmaceutical Industry: SWOT Analysis
Figure 9.2 SWOT Factors: Harvey Ball Analysis
Figure 10.1 Key Applications of Blockchain Across Various Industries
Figure 11.1 Blockchain in Drug Discovery and Clinical Trials Market, 2023-2035 (USD Million)
Figure 11.2 Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Type of Blockchain, 2023 and 2035 (USD Million)
Figure 11.3 Blockchain in Drug Discovery and Clinical Trials Market for Public Blockchain, 2023-2035 (USD Million)
Figure 11.4 Blockchain in Drug Discovery and Clinical Trials Market for Private Blockchain, 2023-2035 USD Million)
Figure 11.5 Blockchain in Drug Discovery and Clinical Trials Market for Hybrid Blockchain, 2023-2035 USD Million)
Figure 11.6 Blockchain in Drug Discovery and Clinical Trials Market for Other Blockchains, 2023-2035 (USD Million)
Figure 11.7 Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Type of End-User, 2023 and 2035 (USD Million)
Figure 11.8 Blockchain in Drug Discovery and Clinical Trials Market for Hospitals, 2023-2035 (USD Million)
Figure 11.9 Blockchain in Drug Discovery and Clinical Trials Market for Pharmaceutical Industry, 2023- 2035 (USD Million)
Figure 11.10 Blockchain in Drug Discovery and Clinical Trials Market for Research Institutes, 2023-2035 (USD Million)
Figure 11.11 Blockchain in Drug Discovery and Clinical Trials Market for Academic Institutes, 2023-2035 (USD Million)
Figure 11.12 Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Key Geographical Regions, 2023 and 2035 (USD Million)
Figure 11.13 Blockchain in Drug Discovery and Clinical Trials Market in North America, 2023-2035 (USD Million)
Figure 11.14 Blockchain in Drug Discovery and Clinical Trials Market in Europe, 2023-2035 (USD Million)
Figure 11.15 Blockchain in Drug Discovery and Clinical Trials Market in Asia- Pacific, 2023-2035 (USD Million)
Figure 11.16 Blockchain in Drug Discovery and Clinical Trials Market in Rest of the World, 2023-2035 (USD Million)
Figure 12.1 Concluding Remarks: Blockchain Technology Providers Market Landscape
Figure 12.2 Concluding Remarks: Partnerships and Collaborations
Figure 12.3 Concluding Remarks: Publication Analysis
Figure 12.4 Concluding Remarks: SWOT Analysis
Figure 12.4 Concluding Remarks: Market Forecast and Opportunity Analysis

List Of Tables

Table 4.1 List of Blockchain Technology Providers
Table 4.2 Blockchain Technology Providers: Information on Type of Blockchain(s)
Table 4.3 Blockchain Technology Providers: Information on Type of Drug Development Application(s)
Table 4.4 Blockchain Technology Providers: Information on Application(s) within Clinical Trial Management
Table 4.5 Blockchain Technology Providers: Information on Type of End-User(s)
Table 6.1 Blockchain in Drug Discovery and Clinical Trials: List of Companies Profiled
Table 6.2 Alten Calsoft Labs: Key Highlights
Table 6.3 Alten Calsoft Labs: Recent Developments and Future Outlook
Table 6.4 ConsenSys: Key Highlights
Table 6.5 ConsenSys: Recent Developments and Future Outlook
Table 6.6 IBM: Key Highlights
Table 6.7 IBM: Recent Developments and Future Outlook
Table 6.8 Stratumn: Key Highlights
Table 6.9 Infosys: Key Highlights
Table 6.10 Infosys: Recent Developments and Future Outlook
Table 6.11 Tech mahindra: Key Highlights
Table 6.12 Tech Mahindra: Recent Developments and Future Outlook
Table 6.13 Blockchain in Drug Discovery and Clinical Trials: List of Companies Profiled
Table 6.14 Humanscape: Key Highlights
Table 6.15 Humanscape: Application Areas of Proprietary Platform
Table 6.16 Humanscape: Recent Developments and Future Outlook
Table 6.17 Hyperledger Foundation: Key Highlights
Table 6.18 Hyperledger Foundation: Application Areas of Proprietary Platform
Table 6.19 Hyperledger Foundation: Recent Developments and Future Outlook
Table 6.20 Innoplexus: Key Highlights
Table 6.21 Innoplexus: Application Areas of Proprietary Platform
Table 6.22 Innoplexus: Recent Developments and Future Outlook
Table 6.23 Medsphere: Key Highlights
Table 6.24 Medsphere: Application Areas of Proprietary Platform
Table 6.25 Medsphere: Recent Developments and Future Outlook
Table 6.26 Solulab: Key Highlights
Table 6.27 Solulab: Application Areas of Proprietary Platform
Table 6.28 Solulab: Recent Developments and Future Outlook
Table 7.1 Blockchain in Drug Discovery and Clinical Trials: List of Partnerships and Collaborations, 2017-2022
Table 10.1 Blockchain Technology in Education: Use Cases
Table 14.1 Blockchain Technology Providers: Distribution by Year of Establishment
Table 14.2 Blockchain Technology Providers: Distribution by Company Size
Table 14.3 Blockchain Technology Providers: Distribution by Region of Headquarters
Table 14.4 Blockchain Technology Providers: Distribution by Location of Headquarters
Table 14.5 Blockchain Technology Providers: Distribution by Year of Establishment, Company Size, and Region of Headquarters
Table 14.6 Blockchain Technology Providers: Distribution by Type of Blockchain(s)
Table 14.7 Blockchain Technology Providers: Distribution by Type of Drug Development Application(s)
Table 14.8 Blockchain Technology Providers: Distribution by Application(s) within Clinical Trial Management
Table 14.9 Blockchain Technology Providers: Distribution by Type of End-User(s)
Table 14.10 Blockchain Technology Providers: Distribution by Type of Blockchain and Type of End-User(s)
Table 14.11 Blockchain Technology Providers: Distribution by Type of Blockchain and Type of Drug Development Application(s)
Table 14.12 Alten Calsoft Labs: Annual Revenues, 2018-H1 2022 (EUR Billion)
Table 14.13 IBM: Annual Revenues, 2018-H1 2022 (USD Billion)
Table 14.14 Infosys: Annual Revenues, 2018-H1 2022 (USD Billion)
Table 14.15 Tech Mahindra: Annual Revenues, 2018-H1 2022 (USD Billion)
Table 14.16 Partnerships and Collaborations: Distribution by Year of Partnership, 2017- 2022
Table 14.17 Partnerships and Collaborations: Distribution by Type of Partnership
Table 14.18 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2017-2022
Table 14.19 Partnerships and Collaborations: Distribution by Company Size and Type of Partnership
Table 14.20 Most Active Players: Distribution by Number of Partnerships
Table 14.21 Most Active Players: Distribution by Type of Partnerships
Table 14.22 Partnerships and Collaborations: Distribution by Type of PharmaceuticalApplications
Table 14.23 Partnerships and Collaborations: Distribution by Type of Partner
Table 14.24 Partnerships and Collaborations: Local and International Agreements
Table 14.25 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 14.26 Publication Analysis: Cumulative Year-Wise Trend, 2016-2022
Table 14.27 Publication Analysis: Distribution by Type of Article
Table 14.28 Popular Journals: Distribution by Number of Publications
Table 14.29 Popular Publishers: Distribution by Number of Publications
Table 14.30 Popular Copyright Holders: Distribution by Number of Publications
Table 14.31 Publication Analysis: Distribution by Impact Factor
Table 14.32 Popular Journals: Distribution by Journal Impact Factor
Table 14.33 Blockchain in Drug Discovery and Clinical Trials Market 2023-2035, Conservative, Base, and Optimistic Scenarios, 2023-2035 (USD Million)
Table 14.34 Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Type of Blockchain, 2023 and 2035
Table 14.35 Blockchain in Drug Discovery and Clinical Trials Market for Public Blockchain, 2023-2035: Conservative, Base, and Optimistic Scenarios (USD Million)
Table 14.36 Blockchain in Drug Discovery and Clinical Trials Market for Private Blockchain, 2023-2035: Conservative, Base and Optimistic Scenarios, (USD Million)
Table 14.37 Blockchain in Drug Discovery and Clinical Trials Market for Hybrid Blockchain, 2023-2035: Conservative, Base and Optimistic Scenarios, (USD Million)
Table 14.38 Blockchain in Drug Discovery and Clinical Trials Market for Other Blockchains, 2023-2035: Conservative, Base and Optimistic Scenarios, (USD Million)
Table 14.39 Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Type of End-User, 2023 and 2035
Table 14.40 Blockchain in Drug Discovery and Clinical Trials Market for Hospitals, 2023-2035: Conservative, Base and Optimistic Scenarios, (USD Million)
Table 14.41 Blockchain in Drug Discovery and Clinical Trials Market for Pharmaceutical Industry, 2023-2035: Conservative, Base and Optimistic Scenarios, (USD Million)
Table 14.42 Blockchain in Drug Discovery and Clinical Trials Market for Research Institutes, 2023-2035: Conservative, Base and Optimistic Scenarios, (USD Million)
Table 14.43 Blockchain in Drug Discovery and Clinical Trials Market for Academic Institutes, 2023-2035: Conservative, Base and Optimistic Scenarios, (USD Million)
Table 14.44 Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Key Geographical Regions, 2023 and 2035
Table 14.45 Blockchain in Drug Discovery and Clinical Trials Market in North America, 2023-2035: Conservative, Base and Optimistic Scenarios, (USD Million)
Table 14.46 Blockchain in Drug Discovery and Clinical Trials Market in Europe, 2023-2035: Conservative, Base and Optimistic Scenarios, (USD Million)
Table 14.47 Blockchain in Drug Discovery and Clinical Trials Market in Asia- Pacific, 2023-2035: Conservative, Base and Optimistic Scenarios, (USD Million)
Table 14.48 Blockchain in Drug Discovery and Clinical Trials Market in Rest of the World, 2023-2035: Conservative, Base and Optimistic Scenarios, (USD Million)

List Of Companies

The following companies and organizations have been mentioned in the report:

  1. ACL Digital 
  2. Aculys Pharma 
  3. Akiri
  4. AME Publishing Company
  5. American Medical Association
  6. AOSIS
  7. APPII
  8. BioMed Central
  9. BlockCerts
  10. Blockchain BioPharma (also known as Blockchain Pharmaceuticals)
  11. Blockcube
  12. Blockpharma 
  13. Bloqcube
  14. Blue.cloud
  15. British Medical Association (BMA)
  16. BurstIQ
  17. Cardinal Health
  18. Chainlink
  19. CHR. Michelsen Institute (CMI)
  20. Chronicled 
  21. Clinical Supply Blockchain Working Group (CSBWG)
  22. Clinlogix (acquired by NAMSA)
  23. ClinTex
  24. ConsenSys
  25. ConsilX
  26. Coral Health
  27. Crucial Data Solutions
  28. Crystalchain
  29. Doc.AI 
  30. Elsevier 
  31. Embleema 
  32. Equideum Health
  33. EXOCHAIN
  34. Factom 
  35. FarmaTrust 
  36. FHIRBlocks (acquired by ConsenSys Health)
  37. Frontiers 
  38. Gem 
  39. Gilgamesh
  40. Guardtime
  41. Hashed Health
  42. HealthVerity
  43. Hindawi
  44. Humanscape
  45. Hyperledger Foundation
  46. Hypertrust Patient Data Care (HPDC)
  47. IBM 
  48. Infosys 
  49. Innoplexus 
  50. Institute of Electrical and Electronic Engineers (IEEE)
  51. Intel
  52. International Society of Global Health (ISoGH)
  53. International Trade Administration
  54. iSolve
  55. Jannsen
  56. Jireh Group
  57. Joule 
  58. LabCorp
  59. LEA LABS
  60. LedgerDomain
  61. LTO Network
  62. Luna
  63. Mary Ann Liebert
  64. Matrix Medical Communications
  65. Mayo Clinic
  66. MediBloc
  67. Medicalchain 
  68. MediConnect
  69. Medidata
  70. Medsphere
  71. MELLODDY
  72. Missouri State Medical Association
  73. modum 
  74. Multidisciplinary Digital Publishing Institute 
  75. National Academy of Medicine
  76. OCEASOFT
  77. ODEM
  78. PAREXEL
  79. PERSOWN 
  80. PharmaLedger
  81. Pistoia Alliance
  82. PokitDok
  83. Premier Blockchain Hub
  84. Quantoz
  85. SAGE Publishing
  86. SAP
  87. ServBlock
  88. Shivom
  89. Shyft Network
  90. Sichuan Hejia
  91. Social Science Electronic Publishing
  92. Society of Laparoscopic & Robotic Surgeons (SLS)
  93. SoluLab
  94. Sphereon
  95. Springer Publishing
  96. StaTwig
  97. Stratumn 
  98. SUSMED
  99. Systech International 
  100. Tada Cognitive Solutions
  101. Tech Mahindra
  102. The Academy of Medical Sciences
  103. TomoChain
  104. Tracekey Solutions
  105. Triall
  106. Ubiquity Press
  107. VeChain
  108. Wiley 
  109. World Health Organization

Source 1: https://www.researchgate.net/publication/343180596_Applications_of_Blockchain_Technology_in_Clinical_Trials_Review_and_Open_Challenges
Source 2: https://www.geeksforgeeks.org/advantages-and-disadvantages-of-blockchain/

PRICING DETAILS

USD 4,799

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com